Shingrix Injection, Solution
Product Images NDC 58160-849

Product Visual Gallery

This gallery contains 10 technical images submitted to the FDA as part of the official labeling for Shingrix (NDC 58160-849). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Glaxosmithkline Biologicals Sa, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Shingrix-spl-graphic-01 (Shingrix Spl Graphic 01)

An instructional illustration showing the process of withdrawing Adjuvant Suspension Component (liquid) into a syringe from a vial, with an arrow indicating the downward direction of the syringe plunger movement.*

FDA Label Image

Shingrix-spl-graphic-02 (Shingrix Spl Graphic 02)

An illustration showing a syringe positioned above a vial labeled with the number "2," indicating the addition of a lyophilized gE antigen component (powder) to the syringe. This depicts part of the preparation process for the Shingrix (Zoster Vaccine Recombinant, Adjuvanted) injection.*

FDA Label Image

Shingrix-spl-graphic-03 (Shingrix Spl Graphic 03)

An instructional illustration showing three steps of drawing vaccine solution with a syringe from a vial labeled with the number 2. The diagram includes arrows indicating the motion and positioning for proper withdrawal of the vaccine dose.*

FDA Label Image

Shingrix-spl-graphic-04 (Shingrix Spl Graphic 04)

An instructional illustration showing a reconstituted vaccine in a vial with the number '2' on it, connected to a syringe filled with 0.5 mL of liquid, indicating dosage volume. The syringe is marked with graduations and an arrow pointing downward below it.*

FDA Label Image

Shingrix 1 Count Carton (Shingrix Spl Graphic 05)

Label for Shingrix (Zoster Vaccine Recombinant, Adjuvanted) injection, solution, 50 mcg per 0.5 mL by GlaxoSmithKline Biologicals SA. The label instructs that one vial of lyophilized powder and one vial of liquid suspension must be combined before use. It indicates the vaccine is for those 50 years and older and adults 18 years and older who are immunocompromised or at increased risk of herpes zoster.*

FDA Label Image

Shingrix 1 Count Adjuvant Vial Label (Shingrix Spl Graphic 06)

Label from Shingrix Adjuvant Suspension Component vial, showing NDC 58160-829-01. The label includes usage instructions indicating it is not to be used alone and must be added to a vial of lyophilized gE antigen component to form Shingrix. Manufactured by GlaxoSmithKline Biologicals SA.*

FDA Label Image

Shingirx 1 Count Antigen Vial Label (Shingrix Spl Graphic 07)

Label for Shingrix lyophilized gE antigen component vial, part 2 of 2, 0.5 mL single dose after reconstitution. The label highlights that the vial must not be used alone and should be reconstituted with the adjuvant suspension component. Manufactured by GlaxoSmithKline Biologicals, the label includes the NDC number 58160-828-01 and lot/expiration details.*

FDA Label Image

Shingrix 10 Count Carton (Shingrix Spl Graphic 08)

Label for Shingrix (Zoster Vaccine Recombinant, Adjuvanted) injection, solution, showing the vaccine comes as a combination of one vial of lyophilized powder and one vial of liquid suspension to be combined before use. The label indicates 10 doses per pack, each dose 0.5 mL, and is intended for individuals age 50 and older or immunocompromised individuals at increased risk of herpes zoster. The label features the GlaxoSmithKline Biologicals SA logo.*

FDA Label Image

Shingrix 10 Count Adjuvant Vial Label (Shingrix Spl Graphic 09)

Label for Shingrix Adjuvant Suspension Component injection solution, vial 1 of 2, used to be combined with lyophilized gE antigen component to form the Shingrix vaccine. It is manufactured by GlaxoSmithKline Biologicals SA. The label includes a warning that this vial is not to be used alone.*

FDA Label Image

Shingrix 10 Count Antigen Vial Label (Shingrix Spl Graphic 10)

Label for Shingrix 50 ug/0.5 mL injection solution, a zoster vaccine recombinant, adjuvanted. This vial is the lyophilized gE antigen component, marked as vial 2 of 2. It states that it must not be used alone and requires reconstitution with the adjuvant suspension component. Manufacturer is GlaxoSmithKline Biologicals SA.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.